Neurogene Inc. 8-K

What Happened
Neurogene Inc. (NGNE) filed a Form 8-K on March 24, 2026 to announce its financial results for the quarter and year ended December 31, 2025. The company issued a press release reporting those results (attached as Exhibit 99.1) and posted an updated corporate presentation on its website (furnished as Exhibit 99.2). The report was signed by Christine Mikail, President and Chief Financial Officer.

Key Details

• Filing date: March 24, 2026; reporting results for the quarter and year ended December 31, 2025.
• Press release with the financial results is attached as Exhibit 99.1 to the Form 8-K.
• Updated corporate presentation (March 2026) is furnished as Exhibit 99.2 and was posted on the company website.
• Form 8-K was signed by Christine Mikail, President and CFO.

Why It Matters
The 8-K makes Neurogene’s most recent quarterly and full‑year financial results and the company’s updated investor presentation available to shareholders and the market. These materials contain the latest revenue, earnings and operational information investors use to assess company performance and near‑term prospects. Review the attached press release and presentation for the specific financial figures, trends, and any management commentary that could affect investment decisions.